SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-15-001430
Filing Date
2015-03-16
Accepted
2015-03-16 11:49:59
Documents
2
Period of Report
2015-03-04

Document Format Files

Seq Description Document Type Size
1 formthree.html 3  
1 formthree.xml 3 4222
2 EXHIBIT 24 exh_24.htm EX-24 7501
  Complete submission text file 0001171843-15-001430.txt   13019
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4520 EAST WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address
Donley Matthew Maxwell (Reporting) CIK: 0001636642 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33609 | Film No.: 15701745